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Studies using Saccharomyces cerevisiae revealed the existence of a unique family of 
proteins named Sirtuins. Sirtuins are highly conserved all the way from bacteria to 
humans. These proteins play important roles inside the cell, as nicotinamide adenine 
dinucleotide-dependent protein deacetylases. Sirtuins are major regulators of multiple 
cellular functions; they can modify the epigenetic landscape and are able to alter the 
proteome of the cell. Several studies have analyzed the role of sirtuins as a link between 
caloric restriction and aging. However, recent discoveries demonstrate new roles for 
these proteins. Sirtuins have also caught the attention of the biotechnology industry, and 
small molecule activators and inhibitors have been developed. The following review 
describes key aspects of sirtuin biology, presents the current situation of sirtuins in the 
biotechnology industry, and analyzes the emerging roles of sirtuins in cell metabolism, 
chromatin regulation, and cancer. 
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“In our midst are men and women… who are wholly absorbed in cracking the previously 
top secret codes governing the chemistry and physics of things alive. They are, 
moreover, enormously and almost continuously entertained by what they do. Great 
musicians experience a similar rapture, but only so long as they perform before an 
audience. Research scientists on quests to their liking are their own audiences. Their 
performances, which are in their heads, need never stop, not even when they are 
sleeping.”  




Silencing Information Regulator-2 (SIR2) was identified by analyzing a spontaneous 
mutation that arose during routine transfers of Saccharomyces cerevisiae. The particular 
feature of this mutant strain was its inability to inhibit the expression of mating type loci 
HMa and HMα that resulted in sterility, characteristic of MATa/MATα diploid cells.  
However, the precise role of the protein encoded by the mutated gene remained elusive 
for several years.  Sequence comparison to other known proteins shed some light on 
one of the roles of SIR2 as an ADP-ribosyltransferase. Further analysis elucidated the 
role of sirtuins as a new type of histone dependent deacetylases (HDACs class III) with 
the special characteristic that they use NAD+ to exert their function. Because of this 
requirement for NAD, sirtuins act as sensors of the energy state of the cell and regulate 
several biological processes, such as response to DNA damage, cell survival, cell 
metabolism, cell-cycle regulation, and senescence. 
 
Much of the work in the sirtuin field started in the lower organism S. cerevisiae and 
then extended to C. elegans and D. melanogaster. Highly conserved homologs of SIR2 
are present in many organisms, ranging from bacteria to humans. In mammals seven 
sirtuins (SIRT1-SIRT7) have been identified, however only some of them have a well 
characterized function. All of the sirtuins contain a conserved core domain that 
comprises the (NAD+)-binding domain and the catalytic site. However, the amino and 
carboxyl termini vary among all of the sirtuins, giving them the ability to recognize 
different substrates. Additionally the seven mammalian sirtuins are located in different 
cell compartments so each one has specific protein substrates depending on its 




SIRT1 Nucleus, Cytoplasm 
SIRT2 Cytoplasm, Nucleus 






Table 1: Subcellular localization of mammalian sirtuins 
 
Sirtuins became the subject of multiple publications when they were identified as the 
possible link between caloric restriction (CR) and aging. A lot of the work done in the 
sirtuin field is related to this association, and several reviews on these topics have been 
published [1, 2, 3]. However, during the last years sirtuin research has produced very 
interesting discoveries about the molecular mechanisms that link them to metabolic 
(e.g., type 2 diabetes) and neurodegenerative disease, with recent publications 
implicating sirtuins as important players in cancer biology and tumorigenesis. Some 
sirtuins act as tumor suppressor genes, while others participate as oncogenes in tumor 
formation. The roles that sirtuins have in cancer include: promotion of the DNA damage 
repair response, maintenance of genomic stability, regulation of reactive oxygen species 
(ROS) levels and regulation of telomeric chromatin. 
 
Because of the role of sirtuins in aging and different diseases, they have become 
promising drug targets. Small molecules that act as inhibitors or activators of sirtuins 




This review presents the major breakthroughs, the ongoing work in the field of sirtuin 
research, and the emerging roles of these proteins in cell metabolism, chromatin 
regulation and cancer.  In addition the current status of sirtuins as novel drug targets is 
addressed. 
 
Discovery of sirtuins 
SIRtuins (Silencing Information Regulators) 
The mating-type locus (MAT) is responsible for determining the cell type (MATa or 
MATα alleles) in yeast. A complex and well studied process called “mating type 
switching” or interconversion enables some yeast strains to modify their cell type from 
MATa to MATα or vice versa. The mating type switching process depends on two 
additional genes HMLα and HMRa. It consists of copying and inserting the HMLα allele 
into the MAT locus to replace the MATa gene, thereby converting cells from MATa to 
MATα or inserting the HMRa allele into the MAT locus to convert cells from MATα to 
MATa. In their normal location, HMLα and HMRa should always be silent; in this way the 
cell type is exclusively defined by the expression of the MAT gene. Several mutants 
(SIR1-SIR4 [4]), with a sterile phenotype (like MATa/MATα diploid cells) were unable to 
silence the HM loci. One of the mutations was mapped to chromosome 4 and the gene 
locus was named MAR1 (then called SIR2), the founding member of the sirtuin family. 
Further studies revealed that SIR2 was responsible for silencing not just the mating-type 
loci, but also telomeric regions [5]. In addition, SIR2 silences ribosomal RNA genes 
(rDNA) in yeast [6]. 
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ADP-ribosyl transferases and NAD+-dependent deacetylases 
The exact molecular function by which SIR2 silenced different genomic regions 
(mating-type loci, rDNA, telomeres) remained unknown until the enzymatic activity of a 
related protein called CobB in Salmonella typhimurium was elucidated [7].  CobB 
catalyzes the reaction of 5’-phosphate transfer from nicotinic acid mononucleotide to a 
precursor of vitamin B12; this phosphoribosyl-transferase activity was confirmed in 
homologs of SIR2 [8]. 
 
Furthermore, additional work demonstrated that the overexpression of SIR2 in yeast 
resulted in general histone deacetylation [9]. Based on the previous observations, the 
breakthrough experiment that identified the precise enzymatic activity catalyzed by 
sirtuins consisted of incubating diacetylated histone peptides (that corresponded to the 
N-terminus) with purified SIR2 in the presence of NAD+ [10]. Analysis of the incubated 
peptides by mass spectrometry (MS), demonstrated that SIR2 catalyzes an NAD 
dependent deacetylation reaction [11]. 
 
The enzymatic reaction (Figure 1) consists of the hydrolysis of NAD+ that leads to the 
production of nicotinamide (NAM) and ADP-ribose; the latter is coupled to the enzyme, 
generating an enzyme ADP-ribose complex. The acetyl groups on the substrate 
(histone) react with ADP generating the deacetylated protein and 2’-O-acetyl-ADP-ribose 
(OAADRr). The use of NAD+ as a cofactor classified sirtuins as a new type of histone 
deacetylase (HDACs class III).  
 
To assess the intracellullar localization, a fusion of the human SIRT2 to GFP revealed 
that this protein resides in the cytoplasm [12]; this and other evidence [7] suggested that 
histones were not the only substrates of sirtuins.  Now we know that sirtuins also 
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acetylate a wide variety of proteins including: TAFI68 [13], α-tubulin [14], 
acetylcoenzyme A synthase 2 (AceCS2) [15], glutamate dehydrogenase (GDH) [16], p53 
[17], and FOXO transcription factors [18] among others. 
 
From yeast to mammals: sirtuin  homologs 
Homologs of SIR2 (HSTs, HST1-HST4) were identified in yeast [19]. Mutations in 
these proteins have similar but not identical effects on silencing, for example hst3 and 
hst4 double mutants cannot silence telomeric regions. In contrast, overexpression of 
HST1 restores silencing at the HMR in sir2 cells [19]. 
 
Orthologs of SIR2 are present in several organisms (sir-2.1, C. elegans [20]; dSIR2, 
D. melanogaster [21]). Multiple sequence alignment revealed a highly conserved core 
domain, shared by all the SIR2-related proteins, that corresponds to the NAD binding 
pocket and the catalytic site. In addition, phylogenetic analysis of the sirtuin family 
identifies five different classes: Class I to IV, and U [22]. The core domain is comprised 
of 250 amino acids, while the amino and carboxyl termini have variable sequences and 
lengths.  Furthermore, the variable regions can affect their localization [23], and might 
have an impact on substrate recognition and activity. For example, the mammalian 
SIRT3 amino-terminus needs to be proteolytically cleaved in order to activate its 
enzymatic activity [24]. 
 
Regulation of sirtuins 
NADH/NAD+ acts as a cofactor in many vital cell reactions, such as the ones that take 
place in the electron transport chain (ETC). NADH is involved in the generation of ATP, 
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acting as a carrier of electrons from the tricarboxylic acid (TCA) cycle to the ETC 
Complex I where it is oxidized to NAD+, resulting in the translocation of protons to 
generate the gradient that later on will generate ATP. The ratio between NAD+ and 
NADH defines the redox state of the cell, which has an impact on several enzymatic 
reactions including the activity of sirtuins [25]. 
 
Sirtuins are regulated by the [NADH]/[NAD+] ratio inside the cell. Experiments done 
by measuring indirectly the [NADH]/[NAD+] ratio (using lactate and pyruvate levels) 
demonstrate that transcription of SIRT1 is enhanced when the [NADH]/[NAD+] ratio 
increases [25]. Additional experiments, in which nicotinamide phosphoribosyltransferase 
(Nampt) is overexpressed, resulting in the production of NAD+, demonstrated that SIRT1 
enzymatic activity is enhanced in the presence of high NAD+ [26]. In contrast 
nicotinamide, a product of the reactions catalyzed by sirtuins (ADP-ribosylation reaction 
and deacetylation reaction), acts as an inhibitor [26]. A similar mechanism regulates the 
activity of poly(ADPribose) polymerase (PARP), described in the following sections. 
 
NADH/NAD+ levels can be altered by DNA damage and the nutritional status of a cell. 
Because of this and the fact that NAD+ is required for their enzymatic activity, sirtuins are 
cellular sensors that link the energy status inside the cell to their different roles in cell 
metabolism, cancer, and aging. 
Sir2, caloric restriction and aging 
Yeast has been used as a model for studying lifespan extension by counting the 
number of mother cell divisions before senescence.  Some studies showed that lifespan 
in yeast is related to the accumulation of extrachromosomal rDNA circles (ERCs), 
resulting in a reduction of lifespan.  Recombination of the rDNA locus generates these 
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ERCs. The rDNA locus consists of a tandemly repeated unit of 9.1 kb which contains the 
35S rRNA, the 5S rRNA and a nontranscribed spacer (NTS) in between. 
 
A protein involved in the recombination process at the rDNA locus is FOB1. FOB1 
mutants present a reduction in rDNA recombination and less ERCs are generated [27].  
In contrast SIR2 yeast mutants accumulate ERCs and a reduction of lifespan is 
observed. Additional experiments confirm that overexpression of SIR2 homologs in other 
organisms has the same effect in lifespan extension [28]. As expected the interplay 
between sir2 and fob1 regulate ERC generation what results in lifespan alterations. 
 
Separate observations revealed that mice fed with a calorie restricted (CR) diet have 
increased lifespan. However, the exact mechanism or at least some insights into the 
causes remained undiscovered. A landmark paper for the sirtuin area was published by 
Leonard Guarente’s group [29]; this publication shed some light on the mechanism by 
which CR mediates lifespan extension.  In this work it was demonstrated that the 
increase of lifespan induced by caloric restriction was dependent on SIR2. In this way 
sirtuins were linked to CR and aging.  
 
These two publications [28, 29] opened a new line of research in the field of the 
biology of aging where sirtuins have a central role. From then on, many research groups 
began focusing on these molecules and an explosion of experimental data has been 
published. A large fraction of the current scientific literature comprises the role they 
might have in aging [1, 2, 3]. However growing evidence is now accumulating, which 




Sirtuins in cell metabolism 
Cell metabolism involves all the reactions that keep a cell alive; among these 
reactions vital ones are those that provide energy to the cell. Mitochondria are the 
organelles where most of the energy producing pathways converge, so a great part of 
the cell’s metabolism depends on them. SIRT3, SIRT4 and SIRT5 are mainly, if not 
exclusively [30], localized to the mitochondria [23].  In addition, sirtuins are able to sense 
energy levels (NADH/NAD+), and depend on them to exert their function. Furthermore, a 
multiplicity of evidence demonstrates that these sirtuins are able to dramatically modify 
cellular metabolism by activating or inactivating important mitochondrial proteins. 
 
SIRT3 energy metabolism 
Just recently the role of acetylation, at the proteomic level, has been analyzed [31], 
revealing that a large fraction of the proteins that are acetylated are located in the 
mitochondria.  However, the impact that this post-translational modification has on many 
of these proteins is still unknown.  SIRT3 knockout mice exhibit hyperacetylation of 
mulitple mitochondrial proteins, whereas SIRT4 and SIRT5 knockouts do not [32], 
suggesting that SIRT3 seems to be the only protein responsible for the deacetylation of 
multiple mitochondrial targets. Because of its relevance to energy metabolism, the 
effects of deacetylation of two essential mitochondrial proteins mediated by SIRT3 will 




Acetyl-CoA synthetases (AceCSs) are essential enzymes that catalyze the 
conversion of acetate, CoA, and ATP into acetyl CoA (an important intermediate of fatty 
acid biosynthesis and the tricarboxylic acid cycle. Mammals have two of them:  AceCS1 
and AceCS2, and their activity is regulated by acetylation/deacetylation [33]. SIRT1 and 
SIRT3 are the proteins that control the deacetylation of AceCS1 and AceCS2 
respectively [15].  Only the deacetylated form of AceCS2 is active; by this mechanism 
SIRT3 can regulate the levels of acetyl CoA in the mitochondria. 
 
Another essential target of SIRT3 is a subunit that belongs to Complex I of the 
electron transport chain (ETC) called NDUFA9 [34]. Immunoprecipitation experiments 
demonstrate that SIRT3 directly interacts with NDUFA9 and is responsible for its 
acetylation.  Furthermore, this interaction has an effect on the activity of Complex I; 
incubation of mitochondria with exogenous SIRT3 resulted in a higher activity of 
Complex I [34]. 
 
The regulation, mediated by SIRT3, of the two proteins described above has an 
impact on the energy levels of the cell and can explain the observed reduction of ATP in 
SIRT3-/- mouse embryonic fibroblasts [2]. Taking into consideration that Complex I is an 
NADH dehydrogenase and that SIRT3 depends on NAD+ to exert its function, a feed-
forward loop can be established whereby the oxidation of NADH mediated by Complex I 
produces NAD+, which induces SIRT3 enzymatic activity that in turn activates Complex I. 
 
A bigger picture emerges if we consider that SIRT3 promotes the activity of AceCS2 
generating acetyl-CoA. Acetyl-CoA acts as a carrier molecule feeding the TCA cycle (the 
generator of NADH, which in turn is used by Complex I). All these data support the idea 
that SIRT3 is involved in essential mitochondrial metabolic reactions. However, a central 
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question of this field is: If SIRT3 has a vital role for the mitochondria, why do SIRT3-/- 
knock out mice have no altered phenotype under the analyzed conditions [32], despite 
the reduction of ATP that can be observed in SIRT3-/- tissues? 
 
A possible hypothesis for these observations is that at there exists a mechanism able 
to compensate for the loss of SIRT3-/- in the knock out mice but acting only at the whole 
organim level, thereby producing no aparent phenotype.  It is also important to consider 
that the search for a differential phenotype [32] was conducted under basal and mild 
nutritional stress scenarios, thus it cannot be ruled out that under different conditions an 
apparent phenotype would be observed. 
 
SIRT4 in insulin secretion and energy metabolism 
Incubation of SIRT4 with the core histone proteins (H2A, H2B, H3 and H4) in the 
presence of 32P-labeled NAD showed that SIRT4 can transfer an ADP-ribose group to 
H2A [55], whereas no deacetylase activity for this sirtuin has been reported (SIRT4 is 
the only mammalian sirtuin lacking deacetylase activity). Moreover, it was demonstrated 
that an important mitochondrial protein, glutamate dehydrogenase (GDH), is a target of 
SIRT4. 
 
GDH is an enzyme responsible for the conversion of glutamate into α-ketoglutarate 
(an intermediate of the TCA cycle). GDH can be ADP-ribosylated, and this modification 
inhibits its catalytic activity [35]. This inhibition has important effects in the physiology of 




GDH favors the production of ATP by feeding the TCA cycle with α-ketoglutarate. The 
NADH and FADH generated in the TCA cycle are then used by the ETC to produce 
ATP. An increased amount of ATP induced by amino acids is known to stimulate the 
secretion of insulin. SIRT4 is expressed in pancreatic β-cells [56], and can regulate 
insulin secretion by altering the activity of GDH [35]. SIRT4-/- mice present high levels of 
insulin in response to feeding with glutamine and leucine, due to the unrestricted activity 
of GDH. 
 
There is evidence that SIRT4 can also regulate insulin secretion in response to 
glucose by a different mechanism [36]. Mass spectrometric analysis of proteins that co-
immunoprecipitate with SIRT4 identified three proteins involved in insulin secretion: 
insulin-degrading enzyme (IDE) [37], and the subunits ANT2 and ANT3 of the ATP/ADP 
translocase. However, no further experiments were done to demonstrate whether SIRT4 
ADP-ribosylates these proteins, evidence only existing for their interaction. RNAi against 
SIRT4 in insulin secreting cells enhanced insulin secretion in the presence of glucose. 
More work is required to define the exact mechanism by which SIRT4 and its targets 
regulate insulin secretion. 
 
Sirtuins function in chromatin regulation 
Removing epigenetic marks 
Transcriptional silencing of the mating-type loci and telomeric regions of the yeast 
genome correlates with hypoacetylation of core histones [9]. In contrast histone 
acetylation is enriched at promoters of actively transcribed genes.  The rationale behind 
these observations is that acetylation neutralizes the positively charged lysines of 
histone N-terminal tails, which decreases its affinity for DNA [38], opens up chromatin 
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and allows the association of transcription factors. Furthermore, acetylation of specific 
residues is associated with nucleosome assembly resulting in different types of 
chromatin: euchromatin or heterochromatin (including constitutive heterochromatin (CH) 
and facultative heterochromatin (FH)). 
 
It is not within the scope of this review to explain all the acetylation and methylation 
marks on histones, given their dynamism and complexity.  However, to describe sirtuins’ 
function in chromatin regulation, some of these marks will be presented. Acetylation of 
lysine residues (K5, K8, K12, and K16) in histone H4 and the K9 residue of histone H3 
(H3K9) is typical of active chromatin; meanwhile hypoacetylation of these amino acids is 
associated with heterochromatin [39]. Methylation of H3K79 (H3K79me2) marks 
transcriptionally active regions, while methylation of H3K9 and H4K20 (H3K9me3, 









Table 2:  Histone marks associated with SIRT1 
 
As expected, nuclear sirtuins (SIRT1 and SIRT6) regulate chromatin structure by 
deacetylation of histone tails.  SIRT1 is the best-studied member of the mammalian 
sirtuins and the mechanism by which it promotes heterochromatin formation has been 
Histone marks Present in: 
H4K16ac transcriptionally active chromatin 
H3K9ac transcriptionally active chromatin 
H3K79me2 transcriptionally active chromatin 
H3K9me3 repressed chromatin 
H4K20me1 repressed chromatin 
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well characterized [40]. RNAi against SIRT1 correlates with: 1) an increase in H4K16 
and H3K9 acetylation; 2) increase of H3K79me2, and 3) decrease of H3K9me3 and 
H4K20me1. Surprisingly SIRT1 also recruits the non-core histone H1, and deacetylates 
it at the K26 residue; this deacetylation might have the same effect as with the other 
histones (neutralization of the charges); however experiments to verify this have not 
been reported. What is known about H1 histone is the fact that it interacts with the linker 
DNA and favors DNA compaction. Interestingly, H1 has been related to aging 
suggesting a key relation with SIRT1 [41, 42]. However, the exact mechanism remains 
to be discovered. 
 
SIRT1 lacks a DNA binding domain, so in order to deacetylate histones it should 
associate with a larger protein complex. Co-immunoprecipitation experiments for SIRT1 
identified the histone methyl-transferase SUV29H1 as an interacting protein, which 
explains the increase of H3K9me3 associated with SIRT1 activity [43]. SIRT1 interacts 
with SUV39H1 and activates it by deacetylating lysine 266 (K266), a key residue that 
mediates the interaction of different protein domains. The interaction between SIRT1 
and SUV39H1 is an example of a new mechanism, where a deacetylase is able to 
regulate the activity of a methyltransferase establishing an interplay between histone 
modifications, thereby allowing SIRT1 to act as a multifunctional regulator of 
heterochromatin formation.  Like the other sirtuins, SIRT1 activity is dependent on NAD+, 
suggesting that SIRT1 can mediate changes in the global transcription program based 




Sirtuins in cancer 
Role in DNA repair 
Alterations in the mechanisms responsible for DNA repair (base excision repair 
(BER), nucleotide excision repair (NER), nonhomologous end joining (NHEJ), 
homologous  recombination (HR), and double-stranded base (DSB) repair) increase 
genomic instability.  Genomic instability underlies the acquisition of most of the 
hallmarks of cancer, and refers to defects in genome repair and maintenance that 
promote tumor progression [44]. An example of a DNA repair mechanism mutated in 
cancer is the nucleotide-excision repair mechanism (NER). A well studied case is the 
xeroderma pigmentosum syndrome, where mutations in the proteins involved in NER fail 
to repair UV-induced mutations, resulting in skin cancer [45]. 
 
The sirtuin implicated in genomic stability is SIRT6. Experiments implicate SIRT6 in 
BER [46] and DSB (double-stranded breaks) repair [47].  SIRT6-/- mouse embryonic 
fibroblasts (MEFs) present genomic instability, such as chromosomal translocations and 
chromosome fragmentation. Genomic instability can be caused by alterations in one or 
several of the DNA repair mechanisms. Treatment of SIRT6-/- MEFs with several 
mutagens (ionizing radiations (IR), ultraviolet (UV) light, the alkylating agent methyl-
methanesulphonate (MMS), and oxidative agents (H2O2)) demonstrated that these cells 
were sensitive to MMS and H2O2, suggesting a role for SIRT6 in BER. Separate studies 
demonstrate that SIRT6 is also involved in DSB repair [47], [48]. 
 
The BER pathway is responsible for removing small spontaneous mutations of the 
genome such as base oxidation, alkylation, depurination and deamination, caused by 
reactive species and free radical products of cell metabolism. The BER mechanism 
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consists of removal of the damaged DNA base, which is recognized by a lesion-specific 
DNA glycosylase and excised with an apurinic/apyrimidic endonuclease; the resulting 
gap is then filled in by a specialized polymerase called Polβ, and the remaining nicks are 
sealed with a DNA ligase (DNA ligase III). Expression levels of the proteins involved in 
the BER pathway were analyzed in SIRT6-/- and no differences were observed in 
comparison to controls.  Additionally, no direct interaction between SIRT6-/- with a BER 
related protein has been described. Interestingly, Polβ can be inactivated by acetylation. 
It might be possible that the observed increase in sensitivity to MMS and H2O2 of SIRT6-/- 
is due to the inactivity of the acetylated form of Polβ; however no effect on the 
acetylation of Polβ was observed in the SIRT6-/- cells. 
 
Another type of DNA lesion where sirtuins are involved is in DSB repair. Ionizing 
radiation creates DSBs, which consist on two free DNA ends that can recombine with 
other regions of the genome. DSBs generate genomic instability, with tumorigenic 
potential, by inducing mutations and chromosomal translocations. In eukaryotes there 
are conserved mechanisms to repair these lesions. SIRT6 has been implicated in DSB 
repair. Co-immunoprecipitation experiments identified a direct association of SIRT6 with 
a protein complex (DNA-PK holoenzyme) involved in the regulation of DNA DSB repair 
[49].  After exposure to DNA damage agents DNA-PK associates with chromatin at 
regions flanking the DSBs, the same is true of SIRT6 (it appears in the chromatin bound 
fraction). In SIRT6 knockdown cells, exposed to DNA damaging agents, 1) the levels of 
DNA-PK associated with chromatin remained unchanged, 2) H3K9 acetylation slightly 
increased, and 3) the number of DSBs increased.  It is still not known how these three 
observed effects are related and if the small increase of H3K9 acetylation in SIRT 





A separate study identified the poly-ADP-ribose polymerase (PARP) as a protein that 
is mono-ADP-ribosylated by SIRT6 [48]. PARP1 is a protein responsible for poly-ADP-
ribosylating nuclear proteins, in response to DNA damage, and promoting DNA repair. 
The mono-ADP-ribosylation of PARP1 enhances its activity. This is consistent with the 
observations described above, regarding the increased genomic instability present in 
SIRT6 knockdown cells [46]. The role of SIRT6 in cancer needs to be assessed by 
analyzing the levels of SIRT6 in tumors; the results of such experiments will confirm if 
SIRT6 can be classified as a tumor suppressor gene. 
 
Impact of the regulation of SIRT3 on ROS levels 
Otto Warburg back in the 1920s made the following observation: All normal body cells 
meet their energy needs by oxygen respiration, whereas cancer cells meet their energy 
needs in great part by fermentation. The origin of this metabolic difference and its 
implications for cancer cell proliferation is a research area widely studied nowadays. 
This altered metabolism is known as the ‘Warburg effect’ or aerobic glycolysis. Cancer 
cells consume higher amounts of glucose than normal cells and have increased lactate 
production in the presence of oxygen. Proliferating cells incorporate most of the 
available nutrients into macromolecules. The metabolic features of cancer cells that 
distinguish them from normal cells can be summarized as follows: high glycolysis in the 
presence of oxygen and accumulation of building blocks necessary for continuous cell 
proliferation.  This metabolic shift provides tumor cells a growth advantage. SIRT3 has 
been identified as a regulator of the cell metabolism shift to increased glycolysis in 




Analysis of glucose uptake in SIRT3-/- cells revealed higher glucose consumption 
compared to WT cells. Separate studies identified that SIRT3-/- cells also presented with 
an increase level of reactive oxygen species (ROS) [51]. Now it is known how these two 
observations are connected; the role of SIRT3 as a tumor suppressor is accomplished in 
two different ways: 1) regulating the levels of ROS and 2) inhibiting the cell metabolic 
switch to glycolysis during low oxygen conditions mediated by HIF-α. 
 
Increased ROS levels are associated with cancer. ROS (superoxide, hydrogen 
peroxide, hydroxyl radical) act as DNA-damaging agents causing mutations and 
genomic instability. SIRT3 regulation of ROS levels is mediated by the manganese 
superoxide dismutase (MnSOD) protein. Superoxide is generated as a byproduct of 
electron transfer reactions such as the ones that take place in complex I and III during 
respiration. MnSOD catalyzes the conversion of superoxide to hydrogen peroxide, which 
is then converted to water by other enzymes: catalase and peroxidases. MnSOD activity 
is regulated by the reversible acetylation of a lysine residue (lysine 122), which results in 
a decrease in its enzymatic activity [52]. SIRT3 deacetylates MnSOD, which explains the 
high ROS levels present in SIRT3-/- cells [53]. 
 
HIF-1α is a transcription factor responsible for the upregulation of several genes 
(such as the glucose transporters and glycolytic enzymes) that enable cell survival 
during low oxygen conditions. HIF-1α is stabilized under hypoxic conditions by a well-
described mechanism that involves the inhibition of HIF prolyl-hydroxylases, however a 
new mechanism for HIF stabilization, independent of oxygen levels, has been described 
[50]. The new mechanism works as follows: the high levels of ROS observed in SIRT3-/- 
stabilize HIF-1α under normal oxygen conditions.  As a result of HIF-1α stabilization 
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glucose uptake and glycolysis is enhanced resulting in a cellular metabolic shift that 
enables cell proliferation. In this way loss of SIRT3 reprograms cellular metabolism. 
Furthermore, overexpression of SIRT3 can repress the “Warburg effect” in breast cancer 




Caloric restriction in yeast mediates lifespan extension by increasing the activity of 
SIR2 [29]; in other organisms overexpression of SIR2 homologs has the same effect. In 
the case of mice, when they are fed a calorie restricted diet, they display an extension in 
lifespan, increase in SIRT1 expression in certain tissues, and a characteristic phenotype 
that consists of lower levels of cholesterol in the blood, high oxygen consumption and 
more glucose tolerance. Overexpression of SIRT1 in mice has no effect on lifespan but 
interestingly mimics some of the beneficial effects induced by caloric restriction [54] like 
improved glucose homeostasis. 
 
If somehow the activity of sirtuins can be modulated then the effects of caloric 
restriction can be induced in the organism by these means.  Based on this idea libraries 
of small molecules were used to screen for compounds that can activate SIRT1 (the 
most well studied mammalian sirtuin).  The screening used a fluorescent deacetylation 
assay in which human SIRT1 was incubated with a synthetic acetylated peptide (which 
included the K382 residue present in p53, a well known target of SIRT1). The first 
screen identified several SIRT1 inhibitors and only two activators, both polyphenols 
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(quercetin and piceatannol).  Identification of activators rather than inhibitors represents 
a bigger challenge.  A secondary screen focusing more on polyphenol-like compounds 
discovered 15 SIRT1 activators, named sirtuin-activating compounds (STACs) [55]. The 
most potent activator identified was 3,5,4’-trihydroxystilbene (resveratrol) a compound 
present in red wine. Further experiments in yeast confirmed that resveratrol and two 
other compounds (butein and fistein) activate SIR2 and increase lifespan. 
 
Experimental data showed that these compounds increased SIRT1 activity by 
lowering the Km for the acetylated peptide, and for the NAD+ cofactor, explaining the 
observed activity enhancement. Assessing the levels of acetylated p53 in human cells 
treated with a low dose of resveratrol demonstrated that this compound was able to 
increase SIRT1 activity in vivo in one of its targets (p53) [55]. 
 
Additional screens help identified three small molecules (SRT1460, SRT1720 and 
SRT2183) with a structure distinct from resveratrol that activate sirtuins in a similar way 
by lowering the Km for acetylated peptide substrates only [56]. The next step was to 
analyze the effect of STACs in model organisms.  Because of the effect that 
overexpression of SIRT1 has on glucose homeostasis the effects of SRT1460, SRT1720 
and SRT2183 were tested in type 2 diabetes in vivo models [56].  The results indicated 
that these compounds are 100-fold more potent than resveratrol and have a beneficial 
effect on glucose homeostasis and insulin resistance. Based on the evidence that sirtuin 
activity can be modulated, different compounds (new chemical entities, NCEs) have 
been developed to improve SIRT1 targeting. The company called Sirtris is currently 
developing these NCEs and some of them are in clinical trials aimed at demonstrating if 
there are any side effects associated with sirtuin activation. Sirtuins have become 
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promising drug targets, but there is still a long way to go to understand better their roles 
and to modulate their activity for the treatment of human diseases. 
 
Future Perspectives 
Much of what we know today about sirtuins’ effects in the cell have been obtained 
from experimental data where the particular acetylation state of a sirtuin target is 
assessed. For nuclear sirtuins a lot is known about their histone targets and some target 
trancription factors. However, increasing evidence demonstrates that several 
mitochondrial and cytoplamic proteins are acetylated [31].  Their acetylation state 
regulates their activity with an effect on multiple cellular processes. Because of this, a 
systematic analysis, using high-throughput technologies for assessing the acetylation 
state of the entire proteome in the presence and absence of each particular sirtuin, 
needs to be done. This type of analysis will help discover all the protein targets of 
sirtuins, all the pathways regulated by them, and how sirtuins regulate the mitochondrial 
and cytoplasmic acetylome. 
 
Many studies have focused on SIRT1 and a lot is now known concerning regulation 
of its expression in different tissues and its multiple targets. But all the currently 
developed small molecule modulators have as drug target SIRT1.  At the same time an 
analysis of the other mammalian sirtuins should be undertaken. Because all sirtuins are 
dependent on NAD, it is plausible to think that the entire cellular NAD pool is shared by 
all those sirtuins that localize to the same cell compartment. Overactivation of one sirtuin 




High expectations were raised in the non-scientific community when work 
demonstrating that resveratrol (a component contained in red wine) was able to activate 
SIRT1 under the tested conditions, and led to increased lifespan in yeast, worms and 
flies.  However, no beneficial effect on lifespan extension has been observed in SIRT1 
transgenic mice treated with resveratrol. The better route is to analyze the role of sirtuins 
in specific diseases like type 2 diabetes and cancer, and determine if sirtuins can serve 
as drug targets for their treatment. The main goal of using sirtuins as drug targets should 
be to control and cure disease, not to extend lifespan. 
 
Since the discovery that sirtuins are mediators of lifespan extension there has been 
an enormous amount of interest in them. In the past few years thousands of articles 
have been published on this topic, and growing evidence demonstrates that this family of 
proteins are key regulators of cellular metabolism, cancer and aging. However, only part 
of the picture has been discovered. Much more work needs to be done to fully 
understand their role inside the cell in a global context, and how the activity of these 
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 Figure 1. Deacetylation reaction catalyzed by sirtuins  
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